Biotech Business - September 17, 2021
Bioneer enters strategic collaboration
Bioneer has announced a strategic collaboration with the National Biologics Facility (NBF) to commercialize their combined CRO services for mammalian expression of recombinant proteins. The entity, previously named CHO CORE, is one of the largest academic groups in the world working on Chinese Hamster Ovary cell (CHO) modelling and mechanisms. Funded by the Novo Nordisk […]
Collaboration - September 13, 2021
Read the latest issue of our magazine!
Our latest issue, No 03 2021, is out – sign up for a subscription today and stay updated on the Nordic life science industry’s latest progress and challenges. The Nordic life science industry has not only survived, but managed to grow and develop during the pandemic. Read more about how the past 1.5 years have […]
Collaboration - September 8, 2021
Positive results from Scandion Oncology and Alligator Bioscience
Alligator Bioscience and Scandion Oncology have announced the conclusion of their collaboration with a very positive outcome. The purpose of the collaboration was to explore the anti-tumor efficacy of the CD40 antibody mitazalimab in chemotherapy-resistant preclinical tumor models as an addition to chemotherapy (FOLFIRINOX) combined with SCO-101. The hypothesis that was tested was to see […]
Collaboration - September 6, 2021
University of Helsinki collaborates with Boehringer Ingelheim
The Neuroscience Center of the University of Helsinki has entered into a research collaboration with Boehringer Ingelheim on human translational models. The target of the collaboration is to accelerate innovative gene therapy for brain diseases with high medical need. The collaborators will work on improving human brain organoid models to study central nervous system (CNS) […]
Biotech Business - August 18, 2021
Cereno Scientific collaborates with Abbott
Cereno Scientific has announced that a collaboration agreement has been entered with Abbott regarding use of its CardioMEMS HF System in the upcoming Phase II study with Cereno’s drug candidate CS1. The technology will be used to remotely and continously monitor the pulmonary pressure in the Phase II study evaluating CS1 for the treatment of […]
Collaboration - August 11, 2021
Lundbeck enters new research collaboration
Lundbeck will work together with the US-based Rgenta Therapeutics to discover small molecules targeting RNA regulation and splicing of disease-causing genes. “With this strategic R&D collaboration with Rgenta, we continue to supplement our research activities across the value chain. By using Rgenta’s platform capabilities in discovering RNA-targeting small molecules, we aim to pursue novel targets […]
